Articles From: EdR Appoints John V. Arabia to Board of Directors to EXFO Reports Second-Quarter Results for Fiscal 2014


2014/3/25
EdR (NYSE:EDR), a leader in the ownership, development and management of quality collegiate housing, today announced the appointment of John V.
Sign-up for EdR Appoints John V. Arabia to Board of Directors investment picks
2014/3/25
WAYNE, Penn., March 25, 2014 (GLOBE NEWSWIRE) -- Egalet Corporation (Nasdaq:EGLT) ("Egalet") today announced the initiation of the bioequivalence (BE) program for Egalet-001, an abuse-deterrent, extended-release, oral morphine product in development for the treatment of moderate to severe chronic pain.
Sign-up for Egalet Initiates Bioequivalence Studies for Abuse-Deterrent Morphine Egalet-001 investment picks
2014/3/25
Waffle fans can submit unique recipes for chance to win $10,000 grand prize BATTLE CREEK, Mich.
Sign-up for Eggo® Celebrates International Waffle Day With Contest Announcement investment picks
2014/3/25
Elbit Systems of America focused on establishing a culture of ethical excellence FORT WORTH, Texas , March 25, 2014 /PRNewswire/ -- Elbit Systems of America, LLC, a subsidiary of Elbit Systems Ltd., and a leading provider of high performance products, system solutions, and support services, announced today that it has been recognized by the Ethisphere Institute, an independent center of research promoting best practices in corporate ethics and governance, as a 2014 World's Most Ethical Company ® .
Sign-up for Elbit Systems Of America Named As A 2014 World's Most Ethical Company By The Ethisphere Institute investment picks
2014/3/25
Jeremy Burton, Denis Cashman and Jonathan Martin Step Into Elevated EMC Information Infrastructure Roles HOPKINTON, Mass.
Sign-up for EMC Corporation Announces Key Executive Appointments For EMC Information Infrastructure Business investment picks
2014/3/25
FORT LEE, N.J. , March 25, 2014 /PRNewswire/ --  Empire Resources, Inc. (NASDAQ: ERS) , a distributor of value added, semi-finished metal products, announced today that its Board of Directors has declared a regular dividend of $0.025 per share.
Sign-up for Empire Resources Declares 44th Consecutive Quarterly Dividend investment picks
2014/3/25
BEVERLY HILLS, Calif.
Sign-up for ENCORE PLAY And MOVIEPLEX PLAY Join STARZ PLAY On Xbox 360; PLAY Development For Xbox One On Track For 2014 investment picks
2014/3/25
HOUSTON , March 25, 2014 /PRNewswire/ -- Endeavour International Corporation (NYSE: END) (LSE: ENDV) today announced that it will present at the Howard Weil's 42 nd Annual Energy Conference.
Sign-up for Endeavour to Present at the Howard Weil Energy Conference investment picks
2014/3/25
WEST LAFAYETTE, Ind., March 25, 2014 (GLOBE NEWSWIRE) -- Endocyte, Inc. (Nasdaq:ECYT) announced today that it is offering to sell 4.5 million shares of its common stock in an underwritten public offering.
Sign-up for Endocyte, Inc. Announces Proposed Offering of Common Stock investment picks
2014/3/25
Enerplus Announces Cash Dividend for April 2014 and Elimination of Discount on Stock Dividend Program Canada NewsWire CALGARY , March 25, 2014 /CNW/ - Enerplus Corporation ("Enerplus") (TSX: ERF) (NYSE: ERF) announces that a cash dividend in the amount of CDN$0.09 per share will be payable on April 21, 2014 to all shareholders of record at the close of business on April 4, 2014 .
Sign-up for Enerplus Announces Cash Dividend for April 2014 and Elimination of Discount on Stock Dividend Program investment picks
2014/3/25
BILLERICA, Mass., March 25, 2014 (GLOBE NEWSWIRE) -- Entegris, Inc. (Nasdaq:ENTG) today announced the pricing of $360 million of 6.0% senior unsecured notes due 2022.
Sign-up for Entegris Prices $360 Million of Senior Unsecured Notes Related to Financing of Proposed Acquisition of ATMI investment picks
2014/3/25
Enterprise Group, Inc. announces closing of $27.6 million bought deal equity financing including exercise in full of over-allotment option Canada NewsWire /NOT FOR RELEASE IN THE UNITED STATES OR DISSEMINATION OF UNITED STATES NEWS WIRE SERVICES/ ST.
Sign-up for Enterprise Group, Inc. announces closing of $27.6 million bought deal equity financing including exercise in full of over-allotment option investment picks
2014/3/25
Enterprise Products Partners L.P. (NYSE: EPD) announced today that Michael A.
Sign-up for Enterprise Products Partners to Present at Howard Weil Energy Conference investment picks
2014/3/25
Strengthens Digital Content Development and Integration Across Multimedia Platforms SANTA MONICA, Calif.
Sign-up for Entravision Appoints Hilda Garcia to Vice President of Multimedia Content and Community Development investment picks
2014/3/25
HERNDON, Va., March 25, 2014 (GLOBE NEWSWIRE) -- ePlus inc.
Sign-up for ePlus Recognized as Cisco Data Virtualization Authorized Technology Provider Partner in the United States investment picks
2014/3/25
Global Brand and Brokers Well-Positioned for the Future MADISON, N.J. , March 25, 2014 /PRNewswire/ --  ERA Real Estate , a global real estate franchising leader, unveiled a new brand identity today at its 2014 International Business Conference in Los Angeles, Calif.
Sign-up for ERA Real Estate Unveils New Brand Identity investment picks
2014/3/25
http://media.marketwire.com/attachments/200509/224143_logo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1100999&ProfileId=051205&sourceType=1 PALO ALTO, CA --
Sign-up for Essex Property Trust, Inc. Announces Sale of Common Stock Under Equity Distribution Agreement investment picks
2014/3/25
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- European stock markets rebounded from sharp losses on Tuesday, after better-than-expected U.S. consumer-confidence data and as investors speculated the recent run of weak Chinese data will prompt more easing measures from Beijing.
Sign-up for EUROPE MARKETS: European Stocks Jump Most In Three Weeks investment picks
2014/3/25
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- European stock markets rebounded from sharp losses on Tuesday, after better-than-expected U.S. consumer-confidence data and as investors speculated the recent run of weak Chinese data will prompt more easing measures from Beijing.
Sign-up for EUROPE MARKETS: European Stocks Shrug Off Ifo Survey investment picks
2014/3/25
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- European stock markets rebounded from sharp losses on Tuesday, boosted by solid moves for easyJet, Kingfisher and Luxottica, while investors waited for fresh U.S. housing and confidence data to gauge whether the U.S. economy is recovering from an extreme winter.
Sign-up for EUROPE MARKETS: European Stocks Shrug Off Ifo Survey; U.S. Data Ahead investment picks
2014/3/25
European stocks edged higher early Tuesday ahead of a key survey of business confidence in Germany, Europe's largest economy.
Sign-up for European Stocks Edge Higher investment picks
2014/3/25
By Clare Connaghan European stocks rose Tuesday, largely recovering the losses suffered at the start of the week as hopes of more stimulus measures from China offset data showing German business confidence weakened in March.
Sign-up for European Stocks Move Higher investment picks
2014/3/25
By Sara Sjolin, MarketWatch LONDON (MarketWatch) -- European stock markets rebounded from sharp losses on Tuesday, as investors waited for fresh U.S. housing and confidence data to gauge if the U.S. economy is recovering from the extreme winter.
Sign-up for European stocks shrug off Ifo survey; U.S. data ahead investment picks
2014/3/25
http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1100895&ProfileId=051205&sourceType=1 TOLLESON, AZ --
Sign-up for EVO Trillium, LLC Breaks Ground on New CNG Fueling Station at Central Freight Lines Terminal in Fort Worth, Texas investment picks
2014/3/25
SOLANA BEACH, Calif., March 25, 2014 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (Nasdaq:EVOK) , a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today announced its financial results for the fourth quarter and year ended December 31, 2013.
Sign-up for Evoke Pharma Reports Fourth Quarter and Year End 2013 Results investment picks
2014/3/25
Exelixis, Inc. (NASDAQ:EXEL) announced that the Independent Data Monitoring Committee (IDMC) notified the company today that a planned interim analysis of the COMET-1 phase 3 pivotal trial has been completed, and that the IDMC recommended the trial proceed to its final analysis.
Sign-up for Exelixis Provides Update on Ongoing COMET-1 Phase 3 Pivotal Trial in Men with Metastatic Castration-Resistant Prostate Cancer investment picks
2014/3/25
Exelixis, Inc. (NASDAQ:EXEL) today announced that the European Commission has approved COMETRIQ® (cabozantinib) for the treatment of adult patients with progressive, unresectable locally advanced or metastatic medullary thyroid carcinoma (MTC). The European Commission granted conditional marketing authorization following a positive opinion from the European Committee for Medicinal Products for Human Use (CHMP) issued in December 2013.
Sign-up for Exelixis Receives Approval for COMETRIQ® (Cabozantinib) in the European Union for Treatment of Progressive, Unresectable Locally Advanced or Metastatic Medullary Thyroid Carcinoma investment picks
2014/3/25
Sales reach US$51.2 million Bookings attain US$58.7 million (book-to-bill ratio of 1.15) Cash flows from operating activities total US$3.6 million QUEBEC CITY, March 25, 2014 /PRNewswire/ - EXFO Inc. (NASDAQ: EXFO; TSX: EXF) reported today financial results for the second quarter ended February 28, 2014 .
Sign-up for EXFO Reports Second-Quarter Results for Fiscal 2014 investment picks
2014/3/25
EXFO Reports Second-Quarter Results for Fiscal 2014 Canada NewsWire Selected Financial Information (In thousands of US dollars)                           Q2 2014     Q1 2014     Q2 2013                     Sales   $ 51,179   $ 56,003   $ 62,576                     Gross margin *   $ 31,106   $ 34,818   $ 38,912       60.8%     62.2%     62.2% Other selected information:                
Sign-up for EXFO Reports Second-Quarter Results for Fiscal 2014 investment picks
Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Access Your Portfolio Anytime, Anywhere via Your Mobile Device
P   Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)
P   Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)
P   Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Articles From: EdR Appoints John V. Arabia to Board of Directors to EXFO Reports Second-Quarter Results for Fiscal 2014
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity